Aziz Karim - Concepedia

Author

Aziz Karim

Also Known As

A KARIM, A Karim, A. KARIM, A. Karim, AZIZ KARIM, Abdul Mubdi Ardiansar Arifuddin Karim, Ayad Hatim Karim, Azam Khodaeyan Karim, Aziz Karim, Aziz karim

161

Publications

6.8K

Citations

H-Index

108

Concepts

All Affiliations

Takeda (United States)Deerfield (United States)Pharmaceutical Product Development (United States)Sears Holdings (United States)

About

Aziz Karim is an author at Takeda (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	46	3.2K
2	Natural Sciences	6	6	452
3	Health Sciences	4	4	171
4	Engineering	3	3	146
5	Education	1	1	18

Aziz Karim

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
The pharmacokinetics of Norpace. Aziz Karim PubMed Molecular PharmacologyPharmacokinetic ModelingMedicineClinical PharmacologyExperimental Pharmacology	1975	555
Tumor inhibitors. LXXIII. Maytansine, a novel antileukemic ansa macrolide from Maytenus ovatus S. Morris Kupchan, Yasuo Komoda, William A. Court, Journal of the American Chemical Society Pharmaceutical ScienceAntiparasitic AgentImmunologyAltmetric Attention ScorePathology	1972	426
Effects of Celecoxib, a Novel Cyclooxygenase‐2 Inhibitor, on Platelet Function in Healthy Adults: A Randomized, Controlled Trial Philip T. Leese, Richard C. Hubbard, Aziz Karim, The Journal of Clinical Pharmacology	2000	373
Pharmacokinetics of Celecoxib after Oral Administration in Dogs and Humans: Effect of Food and Site of Absorption Susan K. Paulson, Margaret B. Vaughn, Susan M. Jessen, Journal of Pharmacology and Experimental Therapeutics	2001	285
Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia Evert de Jonge, Pascale E. P. Dekkers, Abla A. Creasey, Blood	2000	254
Tumor inhibitors. XLVII. Vernodalin and vernomygdin, two new cytotoxic sesquiterpene lactones from Vernonia amygdalina del S. Morris Kupchan, R.J. Hemingway, Aziz Karim, The Journal of Organic Chemistry Pharmaceutical ScienceAltmetric Attention ScoreMedicinal FungiPharmacotherapyNew Cytotoxic	1969	184
Tumor inhibitors. XLVIII. Taxodione and taxodone, two novel diterpenoid quinone methide tumor inhibitors from Taxodium distichum S. Morris Kupchan, Aziz Karim, Carol Marcks The Journal of Organic Chemistry Molecular PharmacologyPreclinical TherapeuticsMedicinal ChemistryOncologyDonut Icon	1969	152
Metabolism and Excretion of [14C]Celecoxib in Healthy Male Volunteers S. K. Paulson, Jeremy D. Hribar, Norman W. Liu, Drug Metabolism and Disposition	2000	146
Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: A randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes Paul S. Covington, Ronald Christopher, Miles P. Davenport, Clinical Therapeutics Diabetes ManagementDiabetesPharmacologyType 2Multiple-dose Study	2008	136
Spironolactone Metabolism: Steady‐State Serum Levels of the Sulfur‐Containing Metabolites Peter Gardiner, Kathy B. Schrode, David M. Quinlan, The Journal of Clinical Pharmacology	1989	131

Page 1